PENOPEN Film-coated tablet Ref.[50308] Active ingredients: Phenoxymethylpenicillin

Source: Υπουργείο Υγείας (CY)  Revision Year: 2019  Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3506 Limassol, Cyprus

4.1. Therapeutic indications

Pharyngotonsillitis, acute sinusitis, acute otitis media, community-acquired pneumonia, uncomplicated skin and soft tissue infections, cutaneous Lyme infection, tooth abscess.

Official guidelines for the appropriate use of antibacterial agents should be considered.

4.2. Posology and method of administration

Posology

Pharyngotonsillitis, community-acquired pneumonia, uncomplicated skin and soft tissue infections

12.5 mg/kg body weight and dose opportunity. If necessary, the dose may be increased to a maximum of 50 mg/kg per day. Treatment time in case of pharyngotonsillitis: 10 days. For other indications: 7-10 days.

WeightTablet strengthDosage
10-20 kg250 mg1 tablet, 2-3 times daily
20-40 kg250 mg2 tablets, 2-3 times daily
40 kg250 mg4 tablets, 2-3- times daily

Acute otitis media, acute sinusitis, tooth abscess

25 mg/kg body weight per dose.

Duration of treatment for acute otitis media: 5 days, however in patients at risk for complications: 5-10 days, for recurrent acute otitis media: 10 days, acute sinusitis and tooth abscess: 7-10 days.

WeightTablet strengthDosage
10-20 kg250 mg2 tablets, 2-3 times daily
20-40 kg250 mg4 tablets 2-3 times, daily

For patients 40 kg: 1600 mg, 2-3 times daily should be taken. For this group of patients another more appropriate strength of the product should be used.

Cutaneous Lyme disease (Erythema migrans)

Adults and children over 12 years: 1 g 3 times daily for 10 days.

Children under 12 years: 25 mg/kg body weight 3 times daily for 10 days.

Acrodermatitis

For adults with uncomplicated acrodermatitis, a 2 or 3-gram dose is given three times daily for three weeks.

General information regarding the dosage

In order to avoid complications (rheumatic fever), infections caused by beta-hemolysing streptococci are treated for 10 days.

PK/PD data indicate that a three-times per day dose gives an increased clinical efficacy and it is therefore always recommended for serious infections such as pneumonia and erysipelas, and at least in the initial phase of other infections (see section 5.1).

Method of administration

Tablets should be taken on an empty stomach, or one hour before, or two hours after a meal.

In children, the compliance is improved if administration occurs with food.

4.9. Overdose

Toxicity

Large doses are well tolerated. Acute reactions are mainly due to hypersensitivity. Certain risk of hyperkalemia in very severe overdose of penicillin in the potassium salt.

Symptoms

Toxic reactions; nausea, vomiting, diarrhoea, dyselectrolytemia, decreased consciousness, muscle fasciculations, myoclonia, convulsions, coma, haemolytic reactions, renal failure, acidosis.

In exceptional cases, anaphylactic shock may occur within 20-40 minutes.

Treatment

If necessary gastric lavage, charcoal. Symptomatic treatment. In severe cases, hemoperfusion or haemodialysis.

Treatment in case of anaphylactic reaction

Epinephrine (adrenaline) 0.1-0.5 mg slowly IV, hydrocortisone 200 mg intravenously, possibly promethazine 25 mg IV, liquid, correction of acidosis.

6.3. Shelf life

5 years.

6.4. Special precautions for storage

Store below 25°C, protected from light and moisture.

6.5. Nature and contents of container

PVC/Aluminium blisters. Pack sizes of 100, 500 and 1000 film-coated tablets

PP containers with PE closure. Pack sizes of 500 and 1000 film-coated tablets.

Not all pack sizes may be marketed.

6.6. Special precautions for disposal and other handling

No special requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.